AMPA GluA1-flip targeted oligonucleotide therapy reduces neonatal seizures and hyperexcitability

• Nicole M. Lykens,

  Affiliations Graduate Program in Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America, LifeSplice Pharma, Malvern, Pennsylvania, United States of America

  ⨯
• David J. Coughlin,

  Affiliation Department of Biology, Widener University, Chester, Pennsylvania, United States of America

  http://orcid.org/0000-0002-2597-4261

  ⨯
• Jyoti M. Reddi,

  Affiliation Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America

  ⨯
• Gordon J. Lutz ,

  Contributed equally to this work with: Gordon J. Lutz, Melanie K. Tallent

  Affiliations LifeSplice Pharma, Malvern, Pennsylvania, United States of America, Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America

  ⨯
• Melanie K. Tallent

  Contributed equally to this work with: Gordon J. Lutz, Melanie K. Tallent

  * E-mail: melanie.tallent@lifesplicepharma.com

  Affiliations LifeSplice Pharma, Malvern, Pennsylvania, United States of America, Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America

  ⨯